Skip to main content
SpringerLink
Log in
Book cover

Toxin-Induced Models of Neurological Disorders pp 121–137Cite as

MPTP-Treated Mice: A Useful Model for Parkinson’s Disease?

  • Chapter

Abstract

In this chapter we consider whether mice treated with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) represent a suitable model for Parkinson’s disease (PD). We classify the disease model system as one that is capable of reproducing certain aspects of the human disease ranging from pathology to clinical symptoms. Sometimes the development of animal models also aims toward reproducing or at least understanding the etiology and/or the pathophysiology of the disease. In PD, the most apparent neuronal lesion is the degeneration of the dopaminergic neurons in substantia nigra, which terminate in nucleus caudatus and putamen, while the classical triad of symptoms consists of rigidity, hypokinesia, and tremor. As is well known, other neuronal systems also degenerate, and the parkinsonian patient displays a number of clinical symptoms in addition to the three mentioned above.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bloem, B.R., Irwin, I., Buruma, O.J.S., Haan, J., Roos, R.A.C., Tetrud, J.W., and Langston, J.W., 1990, The MPTP model: Versatile contributions to the treatment of idiopathic Parkinson’s disease, J. Neurol Sci. 97:273–293.

    Article  PubMed  CAS  Google Scholar 

  • Bohn, M.C., and Kanuicki, M., 1990, Bilateral recovery of striatal dopamine after unilateral adrenal grafting into the striatum of the 1-methyl-4)(2′-methylphenyl)-1,2,3,6-tetrahydropyridine (2′CH3-MPTP)-treated mouse, J. Neurosci. Res. 25:281–286.

    Article  PubMed  CAS  Google Scholar 

  • Bohn, M.C., Cupit, L., Marciano, F., and Gash, D.M., 1988, Adrenal medullary grafts enhance recovery of striatal dopaminergic fibers, Science 237:913–916.

    Article  Google Scholar 

  • Brouillet, E. and Beal, M.F., 1993, NMDA antagonists partially protect against MPTP induced neurotoxicity in mice, Neuroreport, 4:387–390.

    Article  PubMed  CAS  Google Scholar 

  • Bums, R.A., Chieuh, C.C., Markey, S.P., Elbert, M.H., Jacobowitz, D.M., and Kopin, I.J., 1983, A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Proc. Natl. Acad. Sci. U.S.A. 80:4546–4550.

    Article  Google Scholar 

  • Campbell, K.J., Takada, M., and Hattori, T., 1990, Evidence for retrograde axonal transport of MPP+ in the rat, Neurosci. Lett. 118:51–154.

    Article  Google Scholar 

  • Chan, P., DeLanney, L.E., Irwin, I., Langsten, J.W., and Di Monte, D., 1991, Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain, J. Neurochem. 57:348–351.

    Article  PubMed  CAS  Google Scholar 

  • Chiba, K., Trevor, A., and Castagnoli Jr., N., 1984, Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase, Biochem. Biophys. Res. Commun. 120:1228–1232.

    Article  Google Scholar 

  • Chieuh, C.C., Markey, S.P., Burns, R.S., Johannessen, J.N., Pert, A., and Kopin, I.J., 1984, Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat, Eur. J. Pharmacol. 100:189–194.

    Article  Google Scholar 

  • Cleeter, M.W.J., Cooper, J.M., and Schapira, A.H.V., 1992, Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: Evidence for free radical involvement, J. Neurochem. 58:786–789.

    Article  PubMed  CAS  Google Scholar 

  • Colotla, V.A., Flores, E., Oscos, A., Meneses, A., and Tapia, R., 1990, Effects of MPTP on locomotor activity in mice, Neurotoxicol. Teratol, 12:405–407.

    Article  PubMed  CAS  Google Scholar 

  • Date, I., Feiten, S.Y., and Feiten, D.L., 1989, Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice, Neurosci. Lett. 106:282–286.

    Article  PubMed  CAS  Google Scholar 

  • Date, I., Feiten, S.Y., Olschowka, J.A., and Feiten, D.L., 1990, Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice, Exp. Neurol. 107:197–207.

    Article  PubMed  CAS  Google Scholar 

  • Date, I., Notier, M.F.D., Feiten, S.Y., and Feiten, D.L., 1991, Stereotaxic injection of GD1a ganglioside induces limited recovery of striatal dopaminergic system in MPTP-treated aging mice, J. Neurosci. Res. 28:525–530.

    Article  PubMed  CAS  Google Scholar 

  • Davis, C.G., Williams, A.C., Markey, S.P., Elbert, M.H., Calne, E.D., Reichert, C.M., and Kopin, I.J., 1979, Chronic parkinsonism secondary to intravenous injection of meperidine analogues, Psychiatry Res. 1:249–254.

    Article  PubMed  CAS  Google Scholar 

  • Di Monte, D.A., Wu, E.Y., Irwin, I., DeLanney, L.E., and Langston, J.W., 1992, Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes, GLIA 5:48–55.

    Article  PubMed  Google Scholar 

  • Enz, H., Hefti, F., and Frick, W., 1984, Acute administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain: Effect of chronic pretreatment with MPTP, Eur. J. Pharmacol. 101:37–44.

    Article  PubMed  CAS  Google Scholar 

  • Finiels-Marlier, F., Marini, A.M., Williams, P. and Paul, S.M., 1993, The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-pyridinium toxicity in vitro, J. Neurochem. 60:1968–1971.

    Article  PubMed  CAS  Google Scholar 

  • Fredriksson, A., Plaznik, A., Sundström, E., Jonsson, G., and Archer, T., 1990, MPTP-induced hypoactivity in mice: Reversal by L-dopa, Pharmacol. Toxicol. 67:295–301.

    Article  PubMed  CAS  Google Scholar 

  • Giovanni, A., Sieber, B.-A., Heikkila, R.E., and Sonsalla, P.K., 1991, Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice, J. Pharmacol Exp. Ther. 257:691–697.

    PubMed  CAS  Google Scholar 

  • Hadjiconstantinou, M., Fitkin, J.G., Dalia, A., and Neff, N.H., 1991, Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, J. Neurochem. 57:479–482.

    Article  PubMed  CAS  Google Scholar 

  • Hallman, H., Olson, L., and Jonsson, G., 1984, Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse, Eur. J. Pharmacol. 97:133–136.

    Article  PubMed  CAS  Google Scholar 

  • Hallman, H., Lange, J., Olson, L., Strömberg, I., and Jonsson, G., 1985, Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on brain catecholamine neurons in the mouse, J. Neurochem. 44:117–127.

    Article  PubMed  CAS  Google Scholar 

  • Harik, S.I., Schmidley, J.W., Iacofano, L.A., Blue, P., Arora, P.K. and Sayre, L.M., 1987, On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion fo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat, J. Pharm. Exp. Ther. 241:669–676.

    CAS  Google Scholar 

  • Hasegawa, E., Takeshige, K., Oishi, T., Murai, Y., and Minikami, S., 1990, 1-methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation, and enhances NADH-dependent lipid peroxidation in bovine heart submitrochondrial particles, Biochem. Biophys. Res. Commun. 170:1049–1055.

    Article  PubMed  CAS  Google Scholar 

  • Heikkila, E., 1985, Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources, Eur. J. Pharmacol. 117:131–133.

    Article  PubMed  CAS  Google Scholar 

  • Heikkila, R.E., Hess, A., and Duvoisin, R.C., 1984a, Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, Science 224:1451–1453.

    Article  PubMed  CAS  Google Scholar 

  • Heikkila, R.E., Manzino, L., Cabbat, F.S., and Duvoisin, R.C., 1984b, Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors, Nature 311:467–469.

    Article  PubMed  CAS  Google Scholar 

  • Heikkila, R.E., Hwang, J., Ofori, S., Geller, H.M., and Nicklas, W.J., 1990, Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite, J. Neurochem. 54:743–750.

    Article  PubMed  CAS  Google Scholar 

  • Hotchkiss, A., Eiden, L., Johannessen, J., Chieuh, C., and Markey, S., 1984, Cholinergic actions of the primate parkinsonism agent N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) on cultured adrenal chromaffin cells. Fed. Proc. 43:743.

    Google Scholar 

  • Hovestadt, A., De Jong, G.J., and Meerwaldt, J.D., 1988, Spatial disorientation in Parkinson’s disease: No effect of levodopa substitution therapy, Neurology 38:1802–1803.

    Article  PubMed  CAS  Google Scholar 

  • Janson, A.-M., Agnati, L.F., Fuxe, K., Cintra, A., Sundström, E., Zini, I., Toffano, G., and Goldstein, M., 1988, GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse, Acta Physiol. Scand. 132:587–588.

    Article  PubMed  CAS  Google Scholar 

  • Javitch, J.A., D’Amato, R.J., Strittmatter, S.M., and Snyder, S.H., 1985, Parkinsonism-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. U.S.A. 82:2173–2177.

    Article  PubMed  CAS  Google Scholar 

  • Johannessen, J.N., 1991, A model for chronic neurotoxicity: Long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons, Neurotoxicology 12:285–302.

    PubMed  CAS  Google Scholar 

  • Jonsson, G., Nwanze, E., Luthman, J., and Sundström, E., 1986, Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice, Acta Physiol. Scand. 128:187–194.

    Article  PubMed  CAS  Google Scholar 

  • Kordower, J.H., Feiten, S.Y., Feiten, D.L., and Gash, D.M., 1986, Behavioral sequelae following MPTP administration in mice, in “MPTP: A Neurotoxin Producing a Parkinsonian Syndrome” (S.P. Markey, N. Castagnoli Jr., A.J. Trevor, and I.J. Kopin, eds.), pp. 413–417, Academic Press, Orlando.

    Google Scholar 

  • Kupsch, A., Löschmann, P.A., Sauer, H., Arnold, G., Renner, P., Pufal, D., Burg, M., Wachtel, H., ten Bruggencate, G., and Oertel, W.H., 1992, Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice, Brain Res. 592:74–83.

    Article  PubMed  CAS  Google Scholar 

  • Langston, J.W., and Irwin, I., 1986, MPTP: Current concepts and controversies, Clin. Neuropharmacol. 9:485–507.

    Article  PubMed  CAS  Google Scholar 

  • Langston, J.W., Ballard, P., Tetrud, J.W., and Irwin, I., 1983, Chronic parkinsonism in humans due to a product of meperidine-analog synthesis, Science 219:979–980.

    Article  PubMed  CAS  Google Scholar 

  • Langston, J.W., Irwin, I., and Langston, E.B., 1984, Pargyline prevents MPTP-induced parkinsonism in primates, Science 225:1480–1482.

    Article  PubMed  CAS  Google Scholar 

  • Marini, A.M., and Paul, S.M., 1992, N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis, Proc. Natl. Acad. Sci. 89:6555–6559.

    Article  PubMed  CAS  Google Scholar 

  • Markey, S.P., Johannessen, J.N., Chiueh, C.C., Burns, R.S., and Herkenham, M.A., 1984, Intra-neuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism, Nature 311:464–467.

    Article  PubMed  CAS  Google Scholar 

  • Martin, F.R., Sanchez-Ramos, J., and Rosenthal, M., 1991, Selective and nonselective effects of 1-methyl-4-phenylpyridinium on oxygen consumption in rat striatal and hippocampal slices, J. Neurochem. 57:1340–1346.

    Article  PubMed  CAS  Google Scholar 

  • Melamed, A., Pikarski, E., Goldberg, A., Rosenthal, J., Uzzan, A., and Conforti, N., 1986, Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice, Brain Res. 399:178–180.

    Article  PubMed  CAS  Google Scholar 

  • Michel, P.P., and Agid, Y., 1992, The glutamate antagonist, MK-801, does not prevent dopa-minergic cell death induced by the 1-methyl-4-pyridinium ion (MPP+) in rat dissociated mesencephalic cultures, Brain Res. 597:233–240.

    Article  PubMed  CAS  Google Scholar 

  • Nicklas, W.J., Vyas, I., and Heikkila, R.E., 1985, Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, Life Sci. 36:2503–2508.

    Article  PubMed  CAS  Google Scholar 

  • Ogawa, N., Mizukawa, K., Hirose, Y., Kajita, S., Ohara, S., and Watanabe, Y., 1985, MPTP-induced parkinsonian model in mice: Biochemistry, pharmacology and behavior, Eur. Neurol. 26(suppl) 1:435–441.

    Google Scholar 

  • Otto, D., and Unsicker, K., 1990, Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice, J. Neurosci. 10:1912–1921.

    PubMed  CAS  Google Scholar 

  • Perry, T.L., Yong, V.W., Clavier, R.M., Jones, K., Wright, J.M., Foulks, J.G., and Wall, R.A., 1985, Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse, Neurosci. Less. 60:109–114.

    Article  CAS  Google Scholar 

  • Pileblad, E., and Carlsson, A., 1985, Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain, Neuropharmacology 24:689–692.

    Article  PubMed  CAS  Google Scholar 

  • Pileblad, E., Nissbrandt, H., and Carlsson, A., 1984, Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain, J. Neural Transm. 60:199–203.

    Article  PubMed  CAS  Google Scholar 

  • Pileblad, E., Fornstedt, B., Clark, D., and Carlsson, A., 1985, Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum, J. Pharm. Pharmacol. 37:707–712.

    Article  PubMed  CAS  Google Scholar 

  • Ramsay, R.R., and Singer, T., 1986, Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria, J. Biol. Chem. 261:7885–7587.

    Google Scholar 

  • Ramsay, R.R., Salach, J.I., and Singer, T.P., 1986, Uptake of neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+ linked substrates by MPP+ Biochem. Biophys. Res. Commun. 134:743–748.

    Article  PubMed  CAS  Google Scholar 

  • Riachi, N.J., Behmand, A., and Harik, S.I., 1991, Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains, Brain Res. 555:19–24.

    Article  PubMed  CAS  Google Scholar 

  • Ricaurte, G.A., Langston, J.W., DeLanney, L.E., Irwin, I., and Brooks, J.D., 1985, Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in the mouse striatum, Neurosci. Lett. 59:259–264.

    Article  PubMed  CAS  Google Scholar 

  • Ricaurte, G.A., Irwin, I., Forno, L.S., DeLanney, L.E., Langston, E., and Langston, J.W., 1987, Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra, Brain Res. 403:43–51.

    Article  PubMed  CAS  Google Scholar 

  • Rollema, H., Damsma, G., Horn, A.S., De Vries, J.B., and Westerink, B.H., 1986, Brain dialysis in conscious rats reveals an instantaneous massive release of striatal dopamine in response to MPP+, Eur. J. Pharmacol. 126:345–346.

    Article  PubMed  CAS  Google Scholar 

  • Sanchez-Ramos, J.R., Michel, P., Weiner, W.J., and Hefti, F., 1988, Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: Cytochemical and morphological evidence, J. Neurochem. 50:1934–1944.

    Article  PubMed  CAS  Google Scholar 

  • Schneider, J.S., and Yuwiler, A., 1989, GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism, Exp. Neurol. 105:177–183.

    Article  PubMed  CAS  Google Scholar 

  • Schultz, W., Scarnati, E., Sundström, E., Tsutsumi, T., and Jonsson, G., 1986. The catecholamine uptake blocker nomifensine protects against MPTP-induced parkinsonism in monkeys, Exp. Brain Res. 63:216–220.

    Article  PubMed  CAS  Google Scholar 

  • Scotchner, K.P., Irwin, I., DeLanney, L.E., Langston, J.W., and Di Monte, D., 1990, Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes, J. Neurochem. 54:1295–1301.

    Article  Google Scholar 

  • Sershen, H., Hashim, A., and Lajhta, A., 1987, Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson’s disease, Pharmacol. Biochem. Behav. 28:299–303.

    Article  PubMed  CAS  Google Scholar 

  • Sonsalla, P.K., and Heikkila, R.E., 1986, The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice, Eur. J. Pharmacol. 129:339–345.

    Article  PubMed  CAS  Google Scholar 

  • Sonsalla, P.K., Nicklas, W.J., and Heikkila, R.E., 1989, Rose for excitatory amino acids in methamphetamine-induced nigrostriatal toxicity, Science 243:398–400.

    Article  PubMed  CAS  Google Scholar 

  • Sonsalla, P.K., Zeevalk, G.D., Manzino, L., Giovanni, A., and Nicklas, W.J., 1992, MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-pyridinum in rats, J. Neurochem. 58:1979–1982.

    Article  PubMed  CAS  Google Scholar 

  • Sundström, E., 1988, The parkinsonism-inducing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), Thesis, Karolinska Institutet.

    Google Scholar 

  • Sundström, E., and Jonsson, G., 1985, Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse, Eur. J. Pharmacol. 110:293–299.

    Article  PubMed  Google Scholar 

  • Sundström, E., and Jonsson, G., 1986, Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice, Eur. J. Pharmacol. 122:275–278.

    Article  PubMed  Google Scholar 

  • Sundström, E., Goldstein, M., and Jonsson, G., 1986, Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice, Eur. J. Pharmacol. 131:289–292.

    Article  PubMed  Google Scholar 

  • Sundström, E., Strömberg, I., Tsutsumi, T., Olson, L., and Jonsson, G., 1987, Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57 BL/6 mice: Comparison with three other strains of mice, Brain Res. 405:26–38.

    Article  PubMed  Google Scholar 

  • Sundström, E. Luthman, J., Goldstein, M., and Jonsson, G., 1988, Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 mice, Brain Res. Bull. 21:257–263.

    Article  PubMed  Google Scholar 

  • Sundström, E., Fredriksson, A., and Archer, T., 1990, Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: A model for Parkinson’s disease, Brain Res. 528:181–188.

    Article  PubMed  Google Scholar 

  • Tabatabaei, A., Perry, T.L., Hansen, S., and Krieger, C., 1992, Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in rats, Neurosci. Lett. 141:192–194.

    Article  PubMed  CAS  Google Scholar 

  • Tadano, T, Satoh, N., Sakuma, I., Matsumura, T, Kisara, K., Arai, Y., and Kinemuchi, H., 1987, Behavioral and biochemical changes following acute administration of MPTP and MPP+, Life Sci. 40:1309–1318.

    Article  PubMed  CAS  Google Scholar 

  • Turski, L., Bressler, K., Rettig, K.-J., Löschmann, P.-A., and Wachtel, H., 1991, Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists, Nature 349:414–418.

    Article  PubMed  CAS  Google Scholar 

  • Ungerstedt, U., 1971, Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system, Acta Physiol. Scand. Suppl. 367:69–93.

    PubMed  CAS  Google Scholar 

  • Vriezen, E.R., and Moscovitch, M., 1990, Memory for temporal order and conditional associative-learning in patients with Parkinson’s disease, Neuropsychologia, 28:1283–1293.

    Article  PubMed  CAS  Google Scholar 

  • Wagner, G.C., and Walsh, S.L., 1987, Increased sensitivity of mice to tremorogenic agents following MPP+, Psychopharmacology 92:470–472.

    Article  PubMed  CAS  Google Scholar 

  • Wagner, G.C., Jarvis, M.F., and Rubin, J.G., 1986, L-dopa reverses the effects of MPp toxicity, Psychopharmacology. 88:401–402.

    Article  PubMed  CAS  Google Scholar 

  • Weihmuller, F.B., Hadjiconstantinou, M., and Bruno, J.P., 1988, Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice, Neurosci. Lett. 85:137–142.

    Article  PubMed  CAS  Google Scholar 

  • Whishaw, I.Q., and Dunnett, S.B., 1985, Dopamine depletion, stimulation or blockade in the rat disrupts spatial navigation and locomotion dependent upon beacon or distal cues, Behav. Brain Res. 18:11–29.

    Article  PubMed  CAS  Google Scholar 

  • Willis, G.L., and Donnan, G.A., 1998a, Histochemical, biochemical and behavioural conse- quences of MPTP treatment in C-57 black mice, Brain Res. 402:269–274.

    Article  Google Scholar 

  • Willis, G.L., and Donnan, G.A., 1987b, Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, J. Neurol. Sci. 77:185–191.

    Article  PubMed  Google Scholar 

  • Youngster, S.K., Duvoisin, R.C., Hess, A., Sonsalla, P.K., Kindt, M.V., and Heikkila, R.E., 1986, 1-methyl-4-(2′methylphenyl)-1,2,3,6-tetrahydropyridine (2′-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in mice, Eur. J. Pharmacol. 122:283–287.

    Article  PubMed  CAS  Google Scholar 

  • Yurek, D.M., Deutch, A.Y., Roth, R.H., and Sladek, J.R. Jr., 1989, Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocar-bamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice, Brain Res. 497:250–259.

    Article  PubMed  CAS  Google Scholar 

  • Zuddas, A., Corsini, G.U., Schinelli, S., Barker, J.L., Kopin, I.J., and di Porzio, U., 1989, Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum, Brain Res. 501:11–22.

    Article  PubMed  CAS  Google Scholar 

  • Zuddas, A., Oberto, G., Vaglini, F., Fascetti, F., Fornai, F. and Corsini, G.U., 1992, MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates, J. Neurochem. 59:733–739.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Geriatric Medicine, Karolinska Institutet, Huddinge University Hospital, Huddinge, Sweden

    Erik Sundström, Bengt G. Henriksson, Abdul H. Mohammed & Frédéric Souverbie

Authors
  1. Erik Sundström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bengt G. Henriksson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abdul H. Mohammed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frédéric Souverbie
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. East Tennesee State University, Johnson City, Tennessee, USA

    Michael L. Woodruff

  2. Asbury College, Wilmore, Kentucky, USA

    Arthur J. Nonneman

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sundström, E., Henriksson, B.G., Mohammed, A.H., Souverbie, F. (1994). MPTP-Treated Mice: A Useful Model for Parkinson’s Disease?. In: Woodruff, M.L., Nonneman, A.J. (eds) Toxin-Induced Models of Neurological Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1447-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1447-7_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1449-1

  • Online ISBN: 978-1-4899-1447-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation